Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jiac.2021.04.017 http://scihub22266oqcxt.onion/10.1016/j.jiac.2021.04.017 33962861!8064832!33962861     free     free     free       J+Infect+Chemother 2021 ; 27 (7): 1063-1067 Nephropedia Template TP {{tp|p=33962861|t=2021. Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC(50)) of neutralizing antibodies |pdf=|usr=}}{{33962861}} gab.com Text Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC(50)) of neutralizing antibodies JO: J Infect Chemother http://www.kidney.de/pget.php?&tw=1&pmid=33962861 #FOAvip INTRODUCTION: "Re-infection" with COVID-19 is a growing concern; re-infection cases have reported worldwide. However, the clinical characteristics of SARS-CoV-2 re-infection, including the levels and role of anti-SARS-CoV-2 Spike protein IgG antibodies and the half-maximal concentration (IC(50)) of neutralizing antibodies remain unknown. METHODS: Both the epidemiological and clinical information has been collected during two episodes of COVID-19 in a patient. Laboratory results, including RT-PCR, Ct values, anti-SARS-CoV-2 Spike protein IgG antibodies, and the IC(50) of neutralizing antibodies levels were analyzed on the patient. RESULTS: The patient was a 58-year-old man who developed moderate COVID-19 pneumonia with oxygen demand (cannula 2 L/min) in the first episode. By day 30, he recuperated and was discharged after testing negative for SARS-CoV-2. After two and a half months, his three family members showed COVID-19 symptoms and tested positive for SARS-CoV-2. He tested positive for SARS-CoV-2 once again and was asymptomatic (the second episode). The IC(50) of neutralizing antibodies against SARS-CoV-2 greatly increased from 50.0 mug/mL (after the first episode) to 14.8 mug/mL (after the second episode), and remained strongly reactive (20.1 mul/mL) after 47 days of the second episode. CONCLUSIONS: Epidemiological, clinical, and serological analyses confirmed that the patient had re-infection instead of persistent viral shedding from first infection. Our results suggest that SARS-CoV-2 re-infection may manifest as asymptomatic with increased neutralizing antibody levels. Further studies such as the virus characteristics, immunology, and epidemiology on SARS-CoV-2 re-infection are needed. Twit Text FOAVip Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC(50)) of neutralizing antibodies ????J Infect Chemother http://www.kidney.de/pget.php?&tw=1&pmid=33962861 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33962861 #FOAvip English Wikipedia <ref>{{Cite pmid|33962861}}</ref> Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC(50)) of neutralizing antibodies #MMPMID33962861 Inada M; Ishikane M; Terada M; Matsunaga A; Maeda K; Tsuchiya K; Miura K; Sairenji Y; Kinoshita N; Ujiie M; Kutsuna S; Ishizaka Y; Mitsuya H; Ohmagari N J Infect Chemother 2021[Jul]; 27 (7): 1063-1067 PMID33962861show ga INTRODUCTION: "Re-infection" with COVID-19 is a growing concern; re-infection cases have reported worldwide. However, the clinical characteristics of SARS-CoV-2 re-infection, including the levels and role of anti-SARS-CoV-2 Spike protein IgG antibodies and the half-maximal concentration (IC(50)) of neutralizing antibodies remain unknown. METHODS: Both the epidemiological and clinical information has been collected during two episodes of COVID-19 in a patient. Laboratory results, including RT-PCR, Ct values, anti-SARS-CoV-2 Spike protein IgG antibodies, and the IC(50) of neutralizing antibodies levels were analyzed on the patient. RESULTS: The patient was a 58-year-old man who developed moderate COVID-19 pneumonia with oxygen demand (cannula 2 L/min) in the first episode. By day 30, he recuperated and was discharged after testing negative for SARS-CoV-2. After two and a half months, his three family members showed COVID-19 symptoms and tested positive for SARS-CoV-2. He tested positive for SARS-CoV-2 once again and was asymptomatic (the second episode). The IC(50) of neutralizing antibodies against SARS-CoV-2 greatly increased from 50.0 mug/mL (after the first episode) to 14.8 mug/mL (after the second episode), and remained strongly reactive (20.1 mul/mL) after 47 days of the second episode. CONCLUSIONS: Epidemiological, clinical, and serological analyses confirmed that the patient had re-infection instead of persistent viral shedding from first infection. Our results suggest that SARS-CoV-2 re-infection may manifest as asymptomatic with increased neutralizing antibody levels. Further studies such as the virus characteristics, immunology, and epidemiology on SARS-CoV-2 re-infection are needed. |*Antibodies, Neutralizing[MESH] |*COVID-19[MESH] |Antibodies, Viral[MESH] |Humans[MESH] |Japan[MESH] |Male[MESH] |Middle Aged[MESH] |Reinfection[MESH]Asymptomatic COVID-19 re-infection in a Japanese male by elevated half(epmc).pdf DeepDyve Pubget Overpricing